Stanton L. Gerson, MD

Director, Case Comprehensive Cancer Center

Underserved Populations and Community Research

  • Cancer
  • Cancer stem cells/DNA repair
  • Regenerative medicine
  • Aging

Stanton L. Gerson research primarily focuses on stem cells and DNA repair. Dr. Gerson developed mesenchymal stem cells as a therapeutic infusion for blood stem cell transplantation and for the correction of genetic disorders. This therapy is approaching FDA approval. He also identified a gene therapy strategy method that creates drug-resistant stem cells capable of selectively repopulating the recipient without the need for high dose toxic therapy. This strategy is now used experimentally and clinically throughout the country. In the area of DNA repair, he developed inhibitors of DNA repair to improve the efficacy of anti-cancer agents.